Richard G. Vincent - Jan 3, 2023 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Chief Financial Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Jan 3, 2023
Transactions value $
-$4,517
Form type
4
Date filed
1/5/2023, 05:00 PM
Previous filing
Aug 1, 2022
Next filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Tax liability -$4.52K -4.43K -3.37% $1.02 127K Jan 3, 2023 Direct F1
holding ONCT Common Stock 4.53K Jan 3, 2023 By Family Trust
holding ONCT Common Stock 1.83K Jan 3, 2023 By Child
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.